Achieving health equity takes more than financial resources and good intentions; it requires empowering and supporting new ideas with the potential to improve and flourish. Our guiding principles help us create meaningful and lasting impact.
We support programs that educate under-resourced communities and engage people in healthy behaviors. Improving education and awareness helps at-risk patients have better health outcomes with early diagnosis and quality medical care.
We invest in creative solutions, new approaches and inventive concepts to advance health equity, enabling our grantees to explore their effectiveness and develop data that demonstrates their value.
We work across the full continuum of care from education to diagnosis to treatment to support our grantees’ efforts to give patients longer, healthier lives.
We help our grantees to develop self-sustaining programs that create lasting positive change. We work with governments, civil society organizations, public institutions and private sector sponsors toward the elimination of barriers to improving health outcomes.
Our grantmaking approach
At the Bristol Myers Squibb Foundation, we believe that geographic, economic, racial or social circumstances should not determine health outcomes. We support that conviction with developing grantee relationships focused on cancers, cardiovascular disease and immunologic disease in under-served communities and regions in the world that are less developed and heavily burdened. Currently, we are funding programs in the US, nine African countries, Brazil and China.
To learn more about our grantmaking process, contact us at email@example.com
Evolution of our impact
For decades, we at the Bristol Myers Squibb Foundation and our grantees have improved health outcomes for underserved communities around the world. Relationships are at the core of what we do; they make it possible to create lasting change on a larger scale than we could ever accomplish alone. That’s why we support multifaceted endeavors with organizations serving these communities who are developing innovative, sustainable solutions to improve health outcomes and advance health equity.
Although more people today are surviving cancer, the same is not true for everyone. We are working with grantees in areas where social stigmas, inadequate education, and lack of services contribute to increased mortality rates from cancers.
We seek to improve delivery and utilization of specialty care for immunological disorders to underserved and under-resourced populations in the U.S.
We support programs that provide access to cardiology speciality medical care, social support and services for vulnerable and under-resourced populations in the U.S. to mitigate complications from cardiovascular disease.
We aim to increase diversity of patients enrolled in clinical trials, expand the pipeline of diverse clinical trialists and ultimately enhance the development of therapeutics for all populations.